Skip to content

Infant Formula Safety Modernization Act of 2026

In committee: it can still change before the session ends.

US HR 7867 · House Bill · 119th Congress

Stage
In committee
Started in
House
Sponsors
45
Latest action
Mar 9, 2026

What it does

The Infant Formula Safety Modernization Act of 2026 would amend the Federal Food, Drug, and Cosmetic Act to require infant formula manufacturers to conduct standardized pathogen and microorganism testing of both manufacturing facilities and finished products, including specific testing for pathogens like Clostridium botulinum, and to notify the Secretary of Health and Human Services of any positive test results within one business day. It would also mandate that the FDA notify appropriate congressional committees within one business day of receiving such notifications or issuing official inspection classifications for infant formula facilities. The bill applies to all infant formula…

AI summary · The lawmakers haven’t published an official summary of this bill yet, so 52 wrote this one from the bill’s text.

Read the full textRead it on the official site

Where it stands

  1. Introduced (Done)

    Mar 9, 2026

  2. Committee (Current step)

    In committee · Mar 9, 2026

  3. Floor (Not started)

  4. Law (Not started)

What moved

Loading recorded actions…

Who is involved

Sponsors

The lawmakers who put their names on it, lead sponsors first.

In the news

Reporting that may mention this subject. Possible matches are labeled.

Loading coverage…

Where it goes next

While a bill can still move, the questions are about people and money.

Work with this bill

Infant Formula Safety Modernization Act of 2026 | 52